The award ceremony of the 20th Wu Jieping-Paul Janssen Medical & Pharmaceutical Award ( Wu-Janssen Award ) was held at Capital Medical University on December 10. 15 outstanding scientists were awarded this year for their outstanding contributions to China's medicine and health development. SCU Professor Weimin Li, dean of West China School of Medicine / West China Hospital won the 20th Wu Jieping – Paul Janssen Medical & Pharmaceutical Award.

Professor Weimin Li’s team has long been committed to the basic and clinical transformation research of early diagnosis and treatment of lung cancer. His team is the first to reveal the molecular characteristics of young non-smoking lung cancer patients in China and has redefined the high-risk population of lung cancer. The team has conducted a thorough examination of the molecular mechanism of lung cancer progression by means of multi-component analysis, and found for the first time the key molecular target of lung cancer diagnosis and treatment. Besides, the team has employed a multi-dimensional system to study the early diagnosis of lung cancer, finding a specific molecular marker for early diagnosis of lung cancer. What is more, they have established a lung cancer early diagnosis system of "attaching importance to high risk, standardized screening, systematic evaluation and accurate diagnosis", which has increased the early diagnosis rate of lung cancer from 15% to 46.3%, significantly improving the diagnosis and treatment of lung cancer. Due to his innovative work in the field of lung cancer development, Professor Weimin Li was awarded as an expert of special government allowance of the State Council and a young and middle-aged expert of the National Health Commission of the People’s Republic of China. He has presided over more than 30 scientific research projects at various levels, and the total project funds received from the National Natural Science Foundation has exceeded 59 million yuan. The team has won one first prize of Sichuan Science and Technology Progress Award ( ranking first ), two first prizes of Sichuan Science and Technology Progress Award ( ranking second ) and one first prize of the Chinese Progress Prize in Science. His team has published more than 100 SCI papers in Mol Cancer, Clin Cancer Res, Cancer Res, etc., and obtained 9 patents by the state. Moreover, the team has independently developed DeepLN, ( a pulmonary nodule detection and assessment system ) as well as intelligent lung cancer database.